# DUB THERAPEUTICS INC.: A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | DUB THERAPEUTICS INC. |
| Location | SYRACUSE, NY |
| Project | A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy |
| Project number | 5R44EY038138-02 |
| Mechanism | R44 |
| Institute | National Eye Institute |
| Award | $1,009,284 |
| Awarded | 2026-09-17 |
| Project period | 2025-09-15 to 2027-08-31 |
| UEI | RNZAEDZ7WJG2 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11408609). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.